Lipopolysaccharide-binding protein expression is associated to the metastatic status of osteosarcoma patients
Osteosarcoma (OS) is a rare malignant primary bone tumours characterized by a high genetic and cell composition heterogeneity. Unfortunately, despite the use of drug combinations and the recent development of immunotherapies, the overall survival has not improved in the last four decades. Due to the...
Main Authors: | Clément J.F. Heymann, Christine Bobin-Dubigeon, Javier Muñoz-Garcia, Denis Cochonneau, Emilie Ollivier, Marie-Françoise Heymann, Dominique Heymann |
---|---|
Format: | Article |
Language: | English |
Published: |
Elsevier
2022-10-01
|
Series: | Journal of Bone Oncology |
Subjects: | |
Online Access: | http://www.sciencedirect.com/science/article/pii/S2212137422000410 |
Similar Items
-
Inhibiting Endothelin Receptors with Macitentan Strengthens the Bone Protective Action of RANKL Inhibition and Reduces Metastatic Dissemination in Osteosarcoma
by: Javier Muñoz-Garcia, et al.
Published: (2022-03-01) -
Current Therapeutic Strategies and Novel Approaches in Osteosarcoma
by: Dominique Heymann, et al.
Published: (2013-05-01) -
Anterior Intratumoural Chemotherapy: A Newer Modality of Treatment in Advanced Solid Tumours in Children
by: A.N. Gangopadhyay, et al.
Published: (2008-10-01) -
A Laboratory-based Exploratory Study of Tumour-associated Macrophages and their Subpopulation M1 and M2 by Immunohistochemistry in Primary Breast Carcinoma
by: Gaurav Khichariya, et al.
Published: (2022-01-01) -
In vitro three-dimensional cell cultures for bone sarcomas
by: Javier Munoz-Garcia, et al.
Published: (2021-10-01)